EP.12A.18 Afatinib vs. Osimertinib as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Harboring EGFR Mutations.
| Autor: | Hoang, T.T.A., Nguyen, T.T.T., Pham, C.T.M., Dong, H.Q., Nguyen, K.T. |
|---|---|
| Zdroj: | Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS626-S627, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|